Overcoming Barriers to Effective Treatment and Enrollment on Clinical Trials for Black and Underserved Patients With Multiple Myeloma

Learn from a multidisciplinary panel of experts about state-of-the-art care for patients with multiple myeloma and strategies to improve access to care for underserved patient populations with these on-demand roundtable videos and downloadable slides.

Share

Program Content

Activities

Multiple Myeloma Treatment
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma
Video
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2023

Expires: May 30, 2024

Multiple Myeloma Focus Group
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma – Focus Group Panel Discussion
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Expires: July 30, 2024

Activities

Multiple Myeloma Treatment
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2023

Multiple Myeloma Focus Group
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma: Focus Group Panel Discussion
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Faculty

cover img faculity

Frances (Blevins) Arters, PA-C

Dept of Medicine
Hematology and Medical Oncology
Boston Medical Center
Assistant Professor 
Boston University Chobanian and Avedisian School of Medicine
Boston, MA

cover img faculity

Camille Edwards, MD

CME Co-Course Director
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine, Hematology
Boston, Massachusetts

cover img faculity

Natasha Gross-Jean, RN

NCPD Course Advisor
Registered Nurse
Member, Hematology & Oncology Diversity and Inclusion Committee
Boston Medical Center, Hematology 
Boston, Massachusetts

cover img faculity

Lynnette Henshaw, PharmD, BCOP

Clinical Pharmacy Specialist, Hematology/Oncology
Boston Medical Center 
Boston, Massachusetts

cover img faculity

Ajay K. Nooka, MD, MPH, FACP

Professor
Department of Hematology and Medical Oncology
Associate Director of Clinical Research, Winship Cancer Institute
Medical Director, Winship Data and Technology Applications Share Resource
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Natalie Sanfratello, MPH, CHCP

Senior Program Manager – Quality Improvement, Educational Programs, and Contracts
Barry M. Manuel Center for Continuing Education
Boston University Chobanian & Avedisian School of Medicine
Boston, MA

cover img faculity

Bhavesh Shah, R.Ph, BCOP

Chief Pharmacy Officer
Hematology/Oncology and Specialty Pharmacy
Boston Medical Center Health System
Boston, Massachusetts

cover img faculity

J. Mark Sloan, MD

CME Course Director
Associate Professor
Boston University Chobanian & Avedisian School of Medicine, Hematology
Boston, Massachusetts

cover img faculity

Raphael Szalat, MD, PhD

Program Course Director 
Director, Multiple Myeloma Program
Section of Hematology & Medical Oncology
Department of Medicine
Boston Medical Center
Assistant Professor of Medicine
Boston University Chobanian & Avedisian and School of Medicine 
Boston, MA

Provided by

ProCE Banner
ProCE Banner

Provided by The Boston University School of Medicine Continuing Medical Education Office (BUSM CME), in collaboration with Boston Medical Center (BMC) and Clinical Care Options (CCO)

Supporters

This activity is supported by independent medical education grants from Bristol Myers Squibb, Karyopharm Therapeutics, Pfizer, Inc., and Regeneron Pharmaceuticals, Inc. This activity is also supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Karyopharm Therapeutics

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc